LENZ Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 4.18 M | $194.65 M | 0.00% | 14.88% |
| ALPHA WAVE GLOBAL, LP | 11/13/2025 | 3.61 M | $168.26 M | 0.00% | 12.86% |
| VERSANT VENTURE MANAGEMENT, LLC | 11/10/2025 | 2.66 M | $123.76 M | 100.00% | 9.46% |
| BLACKROCK, INC. | 11/12/2025 | 1.47 M | $68.62 M | 2.84% | 5.25% |
| VANGUARD GROUP INC | 11/07/2025 | 1.33 M | $61.96 M | 3.04% | 4.74% |
| UBS GROUP AG | 11/13/2025 | 1.20 M | $55.97 M | 36.32% | 4.28% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2025 | 1.07 M | $50.00 M | -37.48% | 3.82% |
| 72 INVESTMENT HOLDINGS, LLC | 11/14/2025 | 1.02 M | $47.41 M | 0.00% | 3.62% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 897.62 K | $41.81 M | 0.00% | 3.20% |
| RTW INVESTMENTS, LP | 11/14/2025 | 863.39 K | $40.22 M | 0.00% | 3.07% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 11/14/2025 | 693.04 K | $32.28 M | 100.00% | 2.47% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 627.62 K | $29.23 M | -44.10% | 2.24% |
| FRANKLIN RESOURCES INC | 11/13/2025 | 587.08 K | $27.35 M | 6,756.06% | 2.09% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 454.90 K | $21.19 M | 9.32% | 1.62% |
| STATE STREET CORP | 11/14/2025 | 417.98 K | $19.47 M | 11.25% | 1.49% |
| CITADEL ADVISORS LLC | 11/14/2025 | 399.43 K | $18.61 M | 4,319.94% | 1.42% |
| SATURN V CAPITAL MANAGEMENT LLC | 11/14/2025 | 368.18 K | $17.15 M | 7.56% | 1.31% |
| INVESCO LTD. | 11/13/2025 | 364.27 K | $16.97 M | 36.59% | 1.30% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 349.13 K | $16.26 M | 413.59% | 1.24% |
| SAMSARA BIOCAPITAL, LLC | 11/14/2025 | 343.01 K | $15.98 M | 0.00% | 1.22% |
| POINT72 ASSET MANAGEMENT, L.P. | 11/14/2025 | 340.00 K | $15.84 M | -45.00% | 1.21% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 11/14/2025 | 323.86 K | $15.09 M | 34.94% | 1.15% |
| MORGAN STANLEY | 11/14/2025 | 296.22 K | $13.80 M | -49.40% | 1.05% |
| NUVEEN, LLC | 11/12/2025 | 285.54 K | $13.30 M | 60.22% | 1.02% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 251.13 K | $11.70 M | 1,581.72% | 0.89% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/17/2025 | 242.11 K | $11.28 M | 11.51% | 0.86% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2025 | 236.23 K | $11.00 M | 181.28% | 0.84% |
| CANDRIAM S.C.A. | 11/06/2025 | 228.94 K | $10.66 M | 33.67% | 0.82% |
| SCOGGIN MANAGEMENT LP | 11/13/2025 | 225.00 K | $10.48 M | 12.50% | 0.80% |
| PLUSTICK MANAGEMENT LLC | 11/14/2025 | 200.00 K | $9.32 M | 100.00% | 0.71% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 191.40 K | $8.92 M | 4.44% | 0.68% |
| SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 11/07/2025 | 185.64 K | $8.65 M | 99.02% | 0.66% |
| ALLY BRIDGE GROUP (NY) LLC | 11/14/2025 | 175.36 K | $8.17 M | -48.92% | 0.62% |
| NORTHERN TRUST CORP | 11/14/2025 | 165.28 K | $7.70 M | -3.20% | 0.59% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 160.53 K | $7.48 M | 12.96% | 0.57% |
| RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2025 | 144.51 K | $6.73 M | 226.72% | 0.51% |
| ABRDN PLC | 11/07/2025 | 130.73 K | $6.09 M | 75.98% | 0.47% |
| LORD, ABBETT & CO. LLC | 11/13/2025 | 114.61 K | $5.34 M | -12.99% | 0.41% |
| SOVRAN ADVISORS, LLC | 10/31/2025 | 106.92 K | $3.26 M | 164.50% | 0.38% |
| TYRO CAPITAL MANAGEMENT LLC | 11/13/2025 | 100.67 K | $4.69 M | 100.00% | 0.36% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2025 | 99.40 K | $4.63 M | 100.00% | 0.35% |
| SQUAREPOINT OPS LLC | 11/14/2025 | 89.79 K | $4.18 M | 800.31% | 0.32% |
| LISANTI CAPITAL GROWTH, LLC | 11/04/2025 | 87.75 K | $4.09 M | 142.51% | 0.31% |
| FMR LLC | 11/13/2025 | 87.31 K | $4.07 M | 6.95% | 0.31% |
| NEUBERGER BERMAN GROUP LLC | 11/12/2025 | 84.01 K | $3.91 M | 100.00% | 0.30% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 10/29/2025 | 83.37 K | $3.91 M | 0.08% | 0.30% |
| KNOTT DAVID M JR | 11/12/2025 | 82.00 K | $3.82 M | 0.00% | 0.29% |
| EAM INVESTORS, LLC | 11/14/2025 | 80.19 K | $3.68 M | 100.00% | 0.29% |
| ENSIGN PEAK ADVISORS, INC | 11/13/2025 | 77.28 K | $3.60 M | 0.00% | 0.28% |
| CALAMOS ADVISORS LLC | 10/20/2025 | 77.27 K | $3.60 M | 339.89% | 0.28% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
LENZ Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 172 institutional investors and hedge funds held shares of LENZ Therapeutics, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 4.18 M
Alpha Wave Global, LP: 3.61 M
Versant Venture Management, LLC: 2.66 M
BlackRock, Inc.: 1.47 M
VANGUARD GROUP INC: 1.33 M
UBS Group AG: 1.2 M
103.78% of LENZ Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 30.12 M shares in the last 24 months. This purchase volume represents approximately $1.47 B in transactions.